Lobe Sciences Stock Short Ratio
| LOBEF Stock | USD 0.01 0.01 950.00% |
Lobe Sciences fundamentals help investors to digest information that contributes to Lobe Sciences' financial success or failures. It also enables traders to predict the movement of Lobe OTC Stock. The fundamental analysis module provides a way to measure Lobe Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lobe Sciences otc stock.
Lobe |
Lobe Sciences OTC Stock Short Ratio Analysis
Lobe Sciences' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Lobe Sciences has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Lobe Fundamentals
| Return On Equity | -2.8 | |||
| Return On Asset | -0.65 | |||
| Current Valuation | (6.77 M) | |||
| Shares Outstanding | 76.97 M | |||
| Shares Owned By Insiders | 2.85 % | |||
| Price To Earning | 1.34 X | |||
| Price To Book | 0.76 X | |||
| Price To Sales | 7.72 X | |||
| Gross Profit | 841.56 K | |||
| EBITDA | (4.11 M) | |||
| Net Income | (12.25 M) | |||
| Cash And Equivalents | 1.38 M | |||
| Cash Per Share | 0.04 X | |||
| Current Ratio | 2.23 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (2.73 M) | |||
| Earnings Per Share | (0.31) X | |||
| Beta | 2.64 | |||
| Market Capitalization | 2.01 M | |||
| Total Asset | 1.75 M | |||
| Z Score | -6.6 | |||
| Net Asset | 1.75 M |
About Lobe Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lobe Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lobe Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lobe Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Lobe OTC Stock
Lobe Sciences financial ratios help investors to determine whether Lobe OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lobe with respect to the benefits of owning Lobe Sciences security.